Mediland Pharm Limited Reports Unaudited Consolidated Earnings Results for the Half Year Ended December 31, 2019
February 21, 2020 at 02:07 am EST
Mediland Pharm Limited reported unaudited consolidated earnings results for the half year ended December 31, 2019. For the period, the company reported revenue of AUD 19,393,774 compared to AUD 13,358,134 a year ago. Loss after income tax for the half year attributable to members of the company was AUD 795,249 compared to profit of AUD 378,411 a year ago. Basic loss per share were 0.25 cents compared to earnings of 0.52 cents a year ago.